Best Bioengineering Podcasts (2025)

1
Bioengineering: Dr Hamid Noori, biotech scholar 20:17

16h ago20:17

20:17

Bioengineering is a complex field. In some industries it’s well established, in others still nascent. But one thing is true regardless of where it’s applied – it poses interesting problems. Dr Hamid Noori is one scientist motivated by solving these kinds of big, difficult and (he would say) fun problems. As CEO of bioengineering company, The Cultiv…

1
Treating primary bone cancer: The potential of listeria-based bioengineered bacterial immunotherapy 18:37

3d ago18:37

18:37

Osteosarcoma is an extremely challenging and often aggressive cancer that has particular treatment challenges due to location, changing genotypes, and high recurrence rates. It mostly affects children and young adults under 20 years of age. In a new pharmaphorum podcast, web editor Nicole Raleigh spoke with Paul Romness, president and CEO of OS The…

1
Servier’s ASCO 2025 Data: Advancing IDH-Mutated Cancer Treatment with Tibsovo & Voranigo 9:25

11d ago9:25

9:25

At ASCO 2025, Servier presented data in the IDH-mutated cancer space. Onsite at McCormick Place in Chicago, pharmaphorum web editor Nicole Raleigh spoke with Becky Martin, chief US medical at Servier about the key data from the company’s Tibsovo and Voranigo programmes, as well as the implications for patients and the wider themes of the Congress t…

1
Where innovation meets collaboration: Live from Manchester’s City labs 4.0 38:15

12d ago38:15

38:15

In healthcare, some of the most meaningful innovations happen when the right people are brought together in the right place. True progress depends on systems and infrastructure designed to connect ideas, people, and expertise across sectors. Citylabs 4.0, now open in the heart of Manchester’s Knowledge Quarter on the Oxford Road Corridor, was built…

1
Live from ASCO 2025: Boehringer Ingelheim on unmet needs and oncology innovation 9:57

12d ago9:57

9:57

Boehringer Ingelheim’s data presented at ASCO 2025 reflected the company’s broad pipeline and growing body of evidence supporting innovative therapies for various cancers. In a pharmaphorum podcast recorded onsite at the Congress, web editor Nicole Raleigh spoke with Itziar Canamasas, global head of oncology at Boehringer Ingelheim, for a discussio…

1
#25 What exactly is so bad about death? 2:13:03

13d ago2:13:03

2:13:03

We think that death is bad, but why exactly is it bad? We cannot suffer when we do not exist, so why would it be bad? In this episode we have a long, deep conversation with Professor Travis Timmerman, whose philosophical work delves deeply into the nature and ethics of death. An Associate Professor at Seton Hall University, Professor Timmerman has …

1
Quantum Computing 21:09

14d ago21:09

21:09

What if scientists could use the peculiar world of quantum mechanics to design solutions once thought impossible - changing how we build, heal, and communicate? At Lawrence Livermore National Laboratory, researchers are developing quantum systems that could help us do just that. These machines think differently, tapping into the strange rules of qu…

1
Longevity: Sven Gabor Janszky, future scientist 33:25

14d ago33:25

33:25

For over two decades, Germany's most demanded futurist, Sven Gabor Janszky, has been gathering business leaders across Europe, exposing them to the 'rulebreaking' ideas that are changing our world. In this 24th edition of this event, Sven sits down with host (and international keynote at the congress) Jo Lepore, to discuss the science behind findin…

1
Bringing patients to research centres: Using AI to bring efficiencies forward 19:07

17d ago19:07

19:07

Trends can be predicted, and trends can unfold. Here, Liz Beatty – co-founder and chief strategy of Inato – speaks to the beginnings of a new era in drug development brought on by key technological advances in AI. Historically, large urban academic centres have conducted the majority of clinical trials, leading to such issues as inaccessibility, la…

1
TPX Podcast 2025 Series - EP1: Special Issue on Molecular Pathology 27:41

22d ago27:41

27:41

Aleksandra Zuraw, Podcast Editor of Toxicologic Pathology, interviews authors Ingrid Cornax, Dinesh Bangari, Vinicius Carreira, and Janardhan Kyathanahalli to discuss the Special Issue on Molecular Pathology. The special issue can be found on the TPX journal site here.

1
The need for a science-first mindset: The vaccine landscape today 19:34

24d ago19:34

19:34

As has been widely reported on, immunisation rates, including for flu and RSV, have been falling – at a troubling rate – and diseases like whooping cough and measles have seen a worrying resurgence due to anti-vaxxers. And not just in the US. In a new pharmaphorum podcast, Rebecca Catterick, General Manager for Vaccines, UK & Ireland, at Sanofi, di…

1
Low Counts, High Stakes: Infections After CAR T Therapy 17:00

26d ago17:00

17:00

Dr Katherine Cummins (Haematologist at the Peter MacCallum Cancer Centre and The Royal Melbourne Hospital with a focus on clinical translation of CAR T-cells and Allogeneic Stem Cell Transplantation) joins Alex and Hannah to discuss the long term complications post CAR T, focusing on infections. Katherine discusses the impact of lymphodepleting che…

1
#24 Dr. Valter Longo - The BIG 2025 interview 1:56:47

27d ago1:56:47

1:56:47

There were two reasons why Dr. Valter Longo was featured so prominently in my longevity book Evigt Ung (2022). First, if you had to name a single scientific thread running through the history of longevity research, calorie restriction is hard to beat. And few have done more to modernize and translate that insight into real-world practice than Longo…

1
AI at the Lab 18:42

28d ago18:42

18:42

Artificial intelligence is transforming how science is conducted at Lawrence Livermore National Laboratory. From accelerating drug discovery to optimizing complex experiments, AI is helping researchers work faster, smarter and with greater precision. Today we’ll explore how scientists are using Cognitive Simulation - an AI-driven approach that comb…

1
Scenarios: Paul Saffo, forecaster 1:20:21

28d ago1:20:21

1:20:21

Arguably, the most important thing we need to do when thinking about the future, is to hold our strong opinions weakly. In the world of business strategy, the process of mapping what may lie ahead is usually tempted by a perfected, tried-and-true, method. So what happens when the forecast is wrong? On this episode of Looking Outside we are explorin…

1
EAPs: Market access outside of the US and Western Europe 13:36

29d ago13:36

13:36

Early access programmes (EAPs) for novel medicines are an often-misunderstood strategy outside of western markets. In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with Cem Zorlular, CEO of Er-Kim Pharmaceuticals, a company that has been serving as a regional affiliate for pharma and biotech since 1981 in the CEE and Mediterranean. M…

1
The value of a partner, globally and locally 22:08

1M ago22:08

22:08

With the FDA and EMA releasing their annual reports detailing novel drug approvals in 2024, a new pharmaphorum podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face in the year ahead. Host Nicole Raleigh is joined by Cencora’s Sandra Anderson, SVP of Internationa…

1
Inside the VC Game: Conversations with Rising Stars Morgan Gerlak TCV, Jordan Segall Redpoint Ventures, James Green CRV 44:14

1M ago44:14

44:14

Three top-tier rising VCs – Jordan Siegel (RedPoint), James Green (CRV), and Morgan Gerlak (TCV) – pull back the curtain on venture capital. In this candid conversation, these friends and competitors share their journey from career pivots and childhood lessons to competitive deal wins and investment philosophies. Discover how they evaluate founders…

1
Critical Support: The Essential Role of Carers in CAR T 27:46

1M ago27:46

27:46

Nicole O'Leary - an experienced CAR-T nurse practitioner - discusses the importance of the role of the carer. CAR T therapy is not a solo journey and in this episode, we shine a light on the unsung heroes: the carers. From managing medications and monitoring for side effects to providing emotional support through the highs and lows, carers play a c…

1
#23 Hilarious, brilliant and deadly serious: José Cordeiro's quest to defeat death 1:57:19

1M ago1:57:19

1:57:19

This is our first — and probably our last — episode where the guest has brought with him an actual punch card and proceeds to explain why it is, in fact, caca (which is Spanish for 💩, by the way). Welcome to the wild world of José Cordeiro. Stick around and you might hear anecdotes about Robert Kennedy Jr. in Memphis 🎸, late-night karaoke sessions …

1
The ins and outs of HEOR – A lever for global health 24:56

1M ago24:56

24:56

ISPOR 2025, the leading global conference for Health Economics and Outcomes Research (HEOR), takes place 13th-16th May and marks the 30th anniversary of the organisation. Ahead of the event, web editor Nicole Raleigh spoke with Rob Abbott, CEO and executive director of ISPOR – the leading professional society for HEOR globally – about the ins and o…

1
Jupiter Laser Facility 21:42

1M ago21:42

21:42

From fusion experiments to cancer-fighting tech, the Jupiter Laser Facility is where bold ideas meet billion-watt lasers. In this episode, we go inside the lab where students and scientists alike get hands-on with some of the most powerful laser systems on Earth - turning science fiction into real-world breakthroughs, one laser shot at a time. -- B…

1
Neuroaesthetics: Susan Magsamen, brain science expert 46:30

1M ago46:30

46:30

Art is nice, but it’s not just a nice-to-have. And it’s not relegated to galleries, museums and exclusive circles. Not only is art everywhere in our lives, day in and out, it has a profound impact on our physiology, psychology and our ability to better connect with other people. On this episode of Looking Outside we speak with author of ‘Your Brain…

1
Unpacking Trumps executive order on drug pricing with Alice Valder Curran 26:23

2M ago26:23

26:23

President Donald Trump’s April 15th executive order, “Lowering Drug Prices by Once Again Putting Americans First”, contained a smorgasbord of policy proposals targeting a variety of industry stakeholders. But how much legal force do these different elements have, and what are the concrete takeaways for pharma? To answer these questions and more, ho…

1
AI in drug development: The real hurdle is implementation 12:05

2M ago12:05

12:05

It can take up to 15 years for a new drug to reach the market, and with only 20% of pharmaceutical professionals adopting AI, one thing is clear: innovation in drug development is lagging behind. In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with Andrew Stelzer, head of business development at Unlearn.AI, about how the real hurdle…

1
CAR T and the Brain: Navigating Neurotoxicity 24:54

2M ago24:54

24:54

Dr Valeriya Kuznetsova, a neuropsychologist, joins the Straight and Marrow team to discuss the neurological side effects of CAR T cell therapy, including ICANS (immune effector cell-associated neurotoxicity syndrome). From confusion and seizures to subtle cognitive changes, we explore how these toxicities manifest, why they occur, and what can be d…

1
#22 Aging will be cured within 20 years — here's why | Prof. Derya Unutmaz 1:52:58

2M ago1:52:58

1:52:58

Lately, there's been growing pushback against the idea that AI will transform geroscience in the short term. When Nobel laureate Demis Hassabis told 60 Minutes that AI could help cure every disease within 5–10 years, many in the longevity and biotech communities scoffed. Leading aging biologists called it wishful thinking - or outright fantasy. The…

1
Patients as active consumers of care: AI-driven personalisation in pharma marketing 24:02

2M ago24:02

24:02

Therapy initiation, adherence, and health outcomes are being driven by artificial intelligence (AI)-powered personalisation. Today’s consumers are more active participants in their healthcare. Marketing in the era of consumer-driven healthcare requires new strategies to reach patients with the information they require, and how and when they need it…

1
Driving the drug discovery pipeline: The value of organ-on-a-chip MPS 18:42

2M ago18:42

18:42

In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with Tomasz Kostriezewski, CSO at CN Bio, about single organ-on-a-chip technology and multi-organ microphysiological systems (MPS), as well as accelerating drug discovery pipelines with these new alternative methodologies (NAMs). Clinical trial success rates are very low, with up to 95…

1
Climate Finance: David Carlin, climate leader 52:42

2M ago52:42

52:42

After 200 years of rapid growth, we’re seeing the consequences of putting the planet to the limits of habitability. But with future endless growth goals, and finite resources it’s time we get climate action into the P&L. On this episode of Looking Outside, we’re talking about sizing the impact of climate change, with climate and sustainability lead…

1
CRS, Neurotoxicity & More: Understanding CAR T Side effects 25:26

2M ago25:26

25:26

CAR T-cell therapy is revolutionising cancer treatment, but it comes with unique side effects that every patient and caregiver should understand. In this episode, Dr Hamish Scott joins Alex and Hannah to break down the most common side effects, including cytokine release syndrome (CRS) and neurological toxicities, explaining how they present, how t…

1
Intelligent regulatory compliance and improved patient outcomes 15:10

2M ago15:10

15:10

Across the life sciences, Regulatory Affairs (RA) teams and their colleagues in Quality and Safety are stretched beyond their limits as already impossible demands on their time are compounded by rising health authority expectations. In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with Sonia A. Veluchamy, CEO and co-founder of Celege…

1
Funding Announcement: Anecdotes on Series B Funding, Leadership & Growth | Yair Kuznitsov 20:24

2M ago20:24

20:24

In this episode, we speak with Yair Kuznitsov, CEO and co-founder of Anecdotes. Yair recently led the company through a successful Series B funding round, securing a total of $55 million. Yair provides fascinating insights into the strategic decision to extend Series B rather than rushing to Series C and how Anecdotes is positioned to disrupt the G…

1
Prevention for a healthier, more productive society 15:13

2M ago15:13

15:13

In a new pharmaphorum podcast, recorded during Anthropy 2025: Rebooting Britain, web editor Nicole Raleigh spoke with David Gillen, chief medical officer at Norgine, about the role of prevention in the future of healthcare. Recorded onsite at The Eden Project in Cornwall, the conversation centred around the Adelphi Group-sponsored panel, ‘The Preve…

1
LIVE from SXSW: Spotting signals in noise 44:58

2M ago44:58

44:58

Futures Thinking: Spotting Signals in Turbulent Times In a world of constant flux and uncertainty, the ability to spot signals of change is an essential skill for navigating the future. Volatility has been escalating for over a decade, and the exponential growth of data presents both challenges and opportunities. Understanding how to contextualize …

1
#21 A Physicist's Controversial Take on Why Age Reversal Will Never Work | Peter Fedichev 1:28:15

2M ago1:28:15

1:28:15

Peter Fedichev is a visionary scientist, biotech entrepreneur, and physicist at the forefront of longevity research. With a background in theoretical physics, he has seamlessly merged cutting-edge science with real-world applications, making groundbreaking contributions to the fields of aging, biotechnology, and artificial intelligence in healthcar…

1
Spring Break - We'll Be Back Soon! 1:15

2M ago1:15

1:15

Big Ideas Lab is taking a quick spring break, but the story is far from over. We're continuing to uncover the untold breakthroughs and hidden histories of Lawrence Livermore National Lab. Stay tuned — there’s so much more ahead!By Mission.org, Lawrence Livermore National Laboratory, LLNL, Mission

1
Bioengineering CAR T: From Bench to Bedside 27:41

2M ago27:41

27:41

Have you ever wondered how CAR T Cells are made? Join us for a look behind the curtain of CAR T manufacturing with esteemed scientist Associate Professor Dominic Wall, an acknowledged expert in the field and Chief Scientific Officer of Cell Therapies Pty Ltd.By Yvonne and Alex - Bone Marrow Transplant Specialist Nurses

1
Safeguarding the pharmaceutical supply chain 13:37

3M ago13:37

13:37

As we hear of the volcanic and seismic activity taking place in Iceland this week, pharmaphorum turns back to a conversation with Dean Alms, CPO of Aravo, on how extreme weather highlights the need to make adequate supply chain preparations for the seasons in which the planet pulls out all the stops with the worst of its natural disasters. Having a…

1
Machinists 13:24

3M ago13:24

13:24

Before a laser fires or a rocket launches, machinists make the mission possible. This episode explores the world of machining at Lawrence Livermore National Laboratory—where skilled craftspeople transform raw materials into components for fusion research, national security, and space exploration. From time-tested manual tools to advanced digital ma…

1
For the continuum of mental health we need a whole system, holistic 'healthspan' 35:49

3M ago35:49

35:49

If we don’t address the mental health of young people, that mental health challenge will advance into the adult population of tomorrow. What can be done to address the issue, though? At Anthropy 2025: Rebooting Britain, web editor Nicole Raleigh sat down with Dr Sebastian Vaughn, CEO of Phytome Life Sciences, for an en plein air and explorative con…

1
LIVE from SXSW: Staying human in the age of AI 53:58

3M ago53:58

53:58

Enough with the “Delving” – Staying Human in the Age of AI. Is AI making us better or worse at communicating? On one hand, platforms like ChatGPT have unlocked the ability to instantly create and customize vast reams of messaging – emails, social posts, and more. But the telltale fingerprints of AI, from overused words like “innovative” and “delve,…

1
#20 Want a quick $2 million? Help this guy find a longevity city! | Laurence Ion 1:54:50

3M ago1:54:50

1:54:50

In this episode of LEVITY, we speak with Laurence Ion, a tech entrepreneur whose experience with a rare genetic disease led him to tackle one of humanity's greatest challenges: aging. Starting as a shy coder who 'couldn't talk to strangers,' Laurence has become a movement leader pioneering a bold new approach: creating specialized cities where exte…

1
Space Security 17:40

3M ago17:40

17:40

In the vast silence of space, security is anything but quiet. At Lawrence Livermore National Laboratory, cutting-edge science and strategic defense converge to protect the satellites we rely on—guarding them from cyber threats, kinetic attacks, and space debris. As the risks above grow more complex, we’ll uncover the evolving dangers and the invisi…

1
I Was on the Verge of Death Twice - Tomer Tagrin Cancer Battle & Yotpo Success 1:03:19

3M ago1:03:19

1:03:19

In this powerful episode, Tomer Targin CEO of Yotpo, shares his extraordinary journey of surviving stage 4 lymphoma twice while building a successful company. Tomer reveals how cancer transformed his approach to leadership, family, and life itself. Through meditation, gratitude, and unwavering positivity, he turned devastating diagnoses into fuel f…

1
IRA updates and making sense of the chaos in Washington, with Alice Valder Curran 38:29

3M ago38:29

38:29

Last year, Alice Valder Curran, a partner at Hogan Lovells and a healthcare policy expert in Washington, D.C. joined host Jonah Comstock on the pharmaphorum podcast to talk about the intended and unintended consequences of the drug pricing negotiation provisions in the Inflation Reduction Act. On today’s episode, Curran joins us once again for an u…

1
Tech Transfer 17:45

3M ago17:45

17:45

Today we’ll explore how technologies developed at Lawrence Livermore National Laboratory make their way from the Lab into industry — impacting lives every day, in ways that might surprise you. We’ll explore how scientific breakthroughs like high-peak-power laser peening, 3D metal printing, and more spotlight LLNL’s Innovation and Partnerships Offic…

1
How Orca Security became a $1B+ Cloud Security Company | Gil Geron CEO Orca 54:23

3M ago54:23

54:23

"The biggest risk isn't failing—it's not pushing yourself far enough." — Gil, CEO of Orca Security In this episode, we dive deep with Gil Geron, CEO & co-founder of Orca Security. With over $600M in funding and a unicorn valuation, Gil reveals the mindset that's disrupting the cloud security landscape. This isn't your typical success story. Gil ope…

1
#19 What are the chances humanity will survive this century? | Anders Sandberg 2:09:50

3M ago2:09:50

2:09:50

We have another amazing guest for this episode: Anders Sandberg is a visionary philosopher, futurist, and transhumanist thinker whose work pushes the boundaries of human potential and the future of intelligence. As a senior research fellow at Oxford University’s Future of Humanity Institute until its closing in 2024 Sandberg explores everything fro…

1
Inertial Fusion Energy 18:20

3M ago18:20

18:20

What if we could harness the same energy that powers the stars to fuel our world? Scientists at Lawrence Livermore National Laboratory are working towards turning this vision into reality. In this episode, we explore how fusion works, why it’s fundamentally different from today’s nuclear energy, and how the groundbreaking achievement of ignition at…

Podcasts Worth a Listen

Bioengineering Podcasts

Podcasts Worth a Listen

Quick Reference Guide